Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan.
AUTOR(ES)
Hassell, J R
RESUMO
Corneal specimens obtained during surgery from patients with macular corneal dystrophy and obtained at autopsy from control eyes were incubated in a medium containing radioactive precursors of glycoproteins and proteoglycans. Biosynthetically radiolabeled material was extracted and characterized by using molecular sieve chromatography and specific enzymes. Cells in control corneas synthesized both a chondroitin sulfate proteoglycan and a keratan sulfate proteoglycan similar to those present in monkey and bovine corneas. Cells in macular corneas synthesized a normal chondroitin sulfate proteoglycan but did not synthesize either keratan sulfate or a mature keratan sulfate proteoglycan. Instead, macular corneas synthesized a glycoprotein with unusually large oligosaccharide side chains. This glycoprotein was not detected in normal corneas and is slightly smaller than normal keratan sulfate proteoglycan. The failure to synthesize a mature keratan sulfate proteoglycan may produce corneal opacity and result in blindness. Because of evidence indicating that the corneal keratan sulfate proteoglycan is normally synthesized through a glycoprotein intermediate [Hart, G. W. & Lennarz, W. (1978) J. Biol. Chem. 253-5795-5801], macular corneal dystrophy may be a defect in glycoprotein processing.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=349687Documentos Relacionados
- Cell-surface heparan sulfate: an intercalated membrane proteoglycan.
- Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan.
- Drosophila syndecan: conservation of a cell-surface heparan sulfate proteoglycan.
- Vitelliform macular dystrophy and butterfly-shaped epithelial dystrophy: a continuum?
- Clonal antibodies for core protein of chondroitin sulfate proteoglycan.
